先瑞达医疗科技控股有限公司（股票代码：06669）于2026年9月1日披露8月股份变动月报表，报告期为2026年8月。公告显示，公司法定/注册股本依旧保持在100,000美元，对应10,000,000,000股普通股，面值每股0.00001美元。
截至2026年8月31日，公司已发行股份总数为313,389,171股，无库存股。当月未出现新增发行、购回或注销，也无新增库藏股或限制性股份单位计划、股份奖励计划方面的股份变动。
公司同时确认，截至报告期末，已满足香港联交所关于公众持股量的相关要求。公司董事会声明，本月所有证券发行及股份处理事务均已获正式授权，并符合适用的上市规则及相关法律规定。公告由董事李静签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.